The Biology of Motile Cilia
运动纤毛的生物学
基本信息
- 批准号:10617255
- 负责人:
- 金额:$ 74.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAreaBiochemicalBiologyCell CommunicationCellsChemotaxisChlamydomonasCiliaCilium MicrotubuleComplexCytoplasmDefectDevelopmentDynein ATPaseEnvironmentEnzymesFailureFractionationGenesGreen AlgaeHumanHuman BiologyHuman DevelopmentLaboratoriesLocationMethodsMicrotubulesMixed Function OxygenasesModelingMotorOrganellesOxidation-ReductionPathway interactionsPeptidesPlayProcessRegulationRoleSignal PathwaySignal TransductionSourceSyndromeSystemamidationarmcell motilityciliopathycilium biogenesiscilium motilityextracellularfluid flowgenetic approachinsightinterestmacromolecular assemblymolecular arraynovelreceptorresponse
项目摘要
Cilia are microtubule-based cellular extensions that play key roles in sensing the extracellular environment,
processing developmental signals and generating propulsive force and fluid flow. They also act as secretory
organelles releasing bioactive vesicular ectosomes involved in cell-cell communication and other processes.
Cilia are ancient and complex; in humans, ~5% of all genes are involved in their formation/activity and defects
result in complex syndromes or ciliopathies. For many years, my laboratory has been broadly interested in the
assembly and function of motile cilia, and has a strong record of identifying new opportunities and pursuing them
to reveal novel aspects of ciliary biology – most recently we demonstrated that cilia act as a source of peptidergic
signals. For most studies, we utilize the biciliate unicellular green alga Chlamydomonas as a model due to the
ease of biochemical analysis and large array of molecular genetic approaches available. Over the next five
years, we will pursue two broad areas of focus to address what I consider key questions in ciliary biology.
Although superficially distinct, these two areas are intimately connected, and I anticipate we will be able to
integrate them to yield novel insights into conserved and essential cilia-based pathways.
1) Ciliary Motility: dissecting the dynein motors and control systems that generate ciliary beating and power
retrograde intraflagellar transport (IFT). We plan to focus on three major issues. We will dissect the complex
pathways by which axonemal and IFT dyneins are synthesized and assembled in cytoplasm employing our
newly devised biochemical fractionation methods. Building a cilium is an immensely complex problem in
macromolecular assembly and we will examine how assembly factors control the axonemal incorporation of
outer dynein arms at precise locations on doublet microtubules. We will also study axonemal dynein motor
regulation to a) determine how responses to alterations in Ca2+ and redox poise are combined with curvature
sensing to yield integrated changes in motility, and b) assess how cells sense imposed changes in ciliary beating
and respond by increasing intraciliary levels of the dynein regulator Lis1.
2) Cilia Formation and Peptidergic Signaling: studying the peptide amidating enzyme (peptidylglycine -
amidating monooxygenase; PAM) and its amidated bioactive products in ciliary assembly and cilia-based cell-
cell communication. We recently demonstrated that active PAM occurs in cilia and that PAM loss leads to the
failure of ciliogenesis and disrupts dynein-driven retrograde IFT. Furthermore, PAM-generated amidated
bioactive products are released in cilia-derived vesicular ectosomes and one acts as a chemotactic modulator.
We will build on these observations to identify novel amidated PAM products involved in cilia formation. We will
dissect the pathways leading to regulated amidated product release in ciliary ectosomes and determine
where/when processing of the precursors occurs. We will also pursue the amidated product receptors and their
downstream signaling pathways, which lead to differential regulation of the two motile cilia and chemotaxis.
纤毛是基于微管的细胞扩展,在感知细胞外环境中起关键作用,
处理信号并产生推进力和流体流动。他们也充当分泌物
细胞活性囊泡外神经体与细胞 - 细胞通信和其他过程有关的细胞器。
纤毛是古老而复杂的。在人类中,所有基因的形成/活性和缺陷都参与了所有基因
导致复杂的综合征或纤毛病。多年以来,我的实验室一直对
苏里亚妈妈的集会和功能,并有很大的记录来识别新机会并追求它们
为了揭示纤毛生物学的新方面 - 最近,我们证明了纤毛作为肽能的来源
信号。在大多数研究中,我们利用双细胞单细胞绿色藻类衣原体作为模型
可用的生化分析和大量分子遗传学方法的便利性。在接下来的五个
多年来,我们将追求两个广泛的重点领域,以解决我认为睫状生物学中的关键问题。
尽管超级截然不同,但这两个领域是密切联系的,我希望我们能够
将它们整合为将新颖的见解带入构成且基于纤毛的基于基础的途径。
1)睫状运动:剖析产生睫状动力和力量的动力蛋白电动机和控制系统
逆行内部运输(IFT)。我们计划专注于三个主要问题。我们将剖析综合体
轴突和IFT动力蛋白合成并在细胞质中组装的途径,并采用我们的途径
新设计的生化分级方法。建造纤毛是一个非常复杂的问题
大分子组件,我们将研究组装因子如何控制
在双线微管上的精确位置处的动力蛋白臂。我们还将研究轴突动力蛋白电机
调节a)确定如何将Ca2+和氧化还原毒药改变的反应与曲率结合
感知运动能力的综合变化,b)评估细胞如何施加睫状性跳动的变化
并通过增加动力蛋白调节剂LIS1的内部水平响应。
2)纤毛形成和肽吉尼信号传导:研究辣椒酶(肽基甘氨酸---
纳入单加氧酶; PAM)及其在纤毛组装和基于纤毛的细胞中的生物活性产物
细胞通信。我们最近证明了活性PAM发生在纤毛中,PAM损失导致
纤毛发生的失败并破坏动力蛋白驱动的逆行IFT。此外,PAM生成的胺化
生物活性产物在纤毛衍生的囊泡生态体中释放,一种充当趋化调节剂。
我们将基于这些观察结果,以确定与纤毛形成有关的新型胺化PAM产品。我们将
剖析导致纤毛外生中受调节的胺化产物释放的途径,并确定
前体的处理时间/时发生。我们还将追求胺化的产品受体及其
下游信号通路,导致两位母纤毛和趋化性的差异调节。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
N-Terminal Processing and Modification of Ciliary Dyneins.
- DOI:10.3390/cells12202492
- 发表时间:2023-10-20
- 期刊:
- 影响因子:6
- 作者:
- 通讯作者:
Inherently disordered regions of axonemal dynein assembly factors.
- DOI:10.1002/cm.21789
- 发表时间:2023-09
- 期刊:
- 影响因子:2.9
- 作者:Stephen M King
- 通讯作者:Stephen M King
Isolation of ciliary ectosomes and analysis of amidated peptide-mediated chemotaxis in Chlamydomonas.
衣藻中纤毛胞外体的分离和酰胺化肽介导的趋化性分析。
- DOI:10.1016/bs.mcb.2022.09.009
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Luxmi,Raj;King,StephenM
- 通讯作者:King,StephenM
Methylation of ciliary dynein motors involves the essential cytosolic assembly factor DNAAF3/PF22.
纤毛动力蛋白马达的甲基化涉及必需的胞质组装因子 DNAAF3/PF22。
- DOI:10.1073/pnas.2318522121
- 发表时间:2024
- 期刊:
- 影响因子:11.1
- 作者:Sakato-Antoku,Miho;Patel-King,RamilaS;Balsbaugh,JeremyL;King,StephenM
- 通讯作者:King,StephenM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen M King其他文献
AAA domains and organization of the dynein motor unit.
- DOI:
- 发表时间:
2000-07 - 期刊:
- 影响因子:4
- 作者:
Stephen M King - 通讯作者:
Stephen M King
Stephen M King的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen M King', 18)}}的其他基金
2013 Cilia, Mucus and Mucociliary Interactions Gordon Research Conference
2013 纤毛、粘液和粘液纤毛相互作用戈登研究会议
- 批准号:
8449772 - 财政年份:2013
- 资助金额:
$ 74.99万 - 项目类别:
Molecular Analysis of Flagellar Dynein Function
鞭毛动力蛋白功能的分子分析
- 批准号:
7886090 - 财政年份:2009
- 资助金额:
$ 74.99万 - 项目类别:
MOLECULAR ANALYSIS OF FLAGELLAR DYNEIN FUNCTION
鞭毛动力蛋白功能的分子分析
- 批准号:
2189706 - 财政年份:1995
- 资助金额:
$ 74.99万 - 项目类别:
Molecular Analysis of Flagellar Dynein Function
鞭毛动力蛋白功能的分子分析
- 批准号:
7393704 - 财政年份:1995
- 资助金额:
$ 74.99万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
- 批准号:
10642368 - 财政年份:2023
- 资助金额:
$ 74.99万 - 项目类别:
Protein Phosphorylation Networks in Health and Disease
健康和疾病中的蛋白质磷酸化网络
- 批准号:
10682983 - 财政年份:2023
- 资助金额:
$ 74.99万 - 项目类别:
Project 2: Informing oral nicotine pouch regulations to promote public health
项目 2:告知口服尼古丁袋法规以促进公共卫生
- 批准号:
10666068 - 财政年份:2023
- 资助金额:
$ 74.99万 - 项目类别:
Assessing the real-world impact of a low nicotine product standard for smoked tobacco in New Zealand
评估新西兰低尼古丁产品标准对吸食烟草的现实影响
- 批准号:
10665851 - 财政年份:2023
- 资助金额:
$ 74.99万 - 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 74.99万 - 项目类别: